Filing identity and business context
The supplied filing is Sigma Labs, Inc.’s unaudited Form 10-Q for the quarter ended June 30, 2016—not a filing for Nexttrip, Inc. Sigma Labs develops PrintRite3D quality-assurance software and provides related engineering consulting and metal additive-manufacturing services.
Financial results and liquidity
- Revenue: Q2 2016 revenue was $93,824, down from $196,263 in Q2 2015. First-half revenue was $452,279, up from $381,949. Management attributed first-half revenue mainly to engineering consulting contracts.
- Gross profit and margin: Q2 gross profit was $62,920, or approximately 67%, versus $108,001, or 55%, a year earlier. First-half gross profit was $313,794, or approximately 69%, versus $268,820, or 70%.
- Expenses and losses: The financial statements report Q2 net loss of $741,846 versus $440,367 in 2015, and first-half net loss of $1,212,513 versus $812,248. Q2 basic and diluted loss per share was $0.12; first-half loss per share was $0.19. General and administrative and payroll costs rose; R&D expense declined.
- Cash flow: First-half operating cash use was $914,556, compared with $718,286 in 2015. Investing cash use was $72,265 versus $19,465. Cash declined by $986,821 to $552,988 from $1,539,809 at year-end 2015. No financing cash flows were reported for either first-half period.
- Liquidity and debt: Working capital was $724,784 at June 30, down from $1,785,728 at December 31, 2015. Total liabilities were $219,896, consisting of current liabilities; the filing reports no debt or credit facility. Management said available resources were expected to fund operations through 2016.
Material changes and developments
- Revenue increased year over year for the first half but fell sharply in Q2. Operating losses and operating cash use increased.
- Management linked higher G&A to investor-relations spending, consultants, and increased business activity; payroll growth reflected seven hires since June 2015. R&D spending fell as operations shifted toward production.
- The company completed a 1-for-100 reverse stock split in March 2016 and later doubled authorized common shares to 15 million. It reported 6,219,910 shares outstanding on the balance sheet at June 30; 6,267,577 were reported outstanding as of August 10.
- After quarter-end, the company filed an S-1 registration statement that could permit offerings of up to $23.25 million of securities, including common stock and warrants.
Outlook, risks, and unusual items
- Management expected revenue growth from commercialization of PrintRite3D, consulting work, and contract-manufacturing orders, and anticipated a lower loss in the remainder of 2016, partly offset by higher payroll and growth costs. These are expectations, not assured results.
- As of August 10, the company cited eight active contracts expected to generate up to approximately $263,000 of revenue in the rest of 2016, subject to performance milestones and customers not terminating the contracts.
- The company has a history of losses and negative operating cash flow. Management said further financing would be needed to execute its plans if significant product and service revenue does not materialize; additional financing was not committed and could dilute shareholders or impose onerous debt terms.
- Fixed-price consulting contracts expose the company to cost-estimation and delivery risks. The filing also identifies estimates around long-lived-asset impairment, stock compensation, bad debts, and inventory obsolescence as potentially material.
- The filing’s MD&A reports different net-loss amounts from the financial statements: $712,481 for Q2 and $1,183,148 for the first half. The filing text does not explain the discrepancy.
Important facts for investors to verify
- Confirm the issuer identity: the provided filing is for Sigma Labs, Inc., despite the request metadata naming Nexttrip, Inc.
- Reconcile the MD&A net-loss figures with the amounts in the financial statements before relying on reported loss trends.
- Check the status, milestones, termination terms, and realized revenue from the eight contracts and the stated potential $263,000 of second-half 2016 revenue.
- Review the S-1’s eventual offering terms and any resulting dilution, including potential warrant exercises.
- Assess cash burn and financing needs against the company’s stated expectation that existing resources would cover operations through 2016.